Online Inquiry

pacFA GalCer

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Category Standards
Catalog NO. BPG-3145
Product Name pacFA GalCer
CAS 2456348-71-1
Molecular Formula C39H69N3O8
Molecular Weight 707.98
pacFA GalCer
  • Scheme Design
  • Custom Synthesis
  • cGMP Manufacturing
  • Quality Assurance
  • Product Information
  • References
  • Documents
  • Reviews

Product Information

Description pacFA GalCer is a novel synthetic glycosphingolipid with immense therapeutic potential for autoimmune diseases and cancer. Recent research highlights its profound impact on immune modulation and anti-tumor mechanisms, paving the way for innovative immunotherapeutic approaches across diverse pathological conditions.
Synonyms D-galactosyl-β-1,1'N-(9-(3-pent-4-ynyl-3-H-diazirin-3-yl)-nonanoyl)-D-erythro-sphingosine; D-galactosyl-beta-1,1' N-(9-(3-pent-4-ynyl-3-H-diazirin-3-yl)-nonanoyl)-D-erythro-sphingosine
IUPAC Name N-[(E,2S,3R)-3-hydroxy-1-[(2R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadec-4-en-2-yl]-9-(3-pent-4-ynyldiazirin-3-yl)nonanamide
Canonical SMILES CCCCCCCCCCCCCC=CC(C(COC1C(C(C(C(O1)CO)O)O)O)NC(=O)CCCCCCCCC2(N=N2)CCCC#C)O
InChI InChI=1S/C39H69N3O8/c1-3-5-7-8-9-10-11-12-13-14-15-18-21-25-32(44)31(30-49-38-37(48)36(47)35(46)33(29-43)50-38)40-34(45)26-22-19-16-17-20-24-28-39(41-42-39)27-23-6-4-2/h2,21,25,31-33,35-38,43-44,46-48H,3,5-20,22-24,26-30H2,1H3,(H,40,45)/b25-21+/t31-,32+,33+,35-,36?,37?,38+/m0/s1
InChIKey GQEQPMYLTJEVQU-NXDYBQPVSA-N
Purity >95%
Appearance Powder
Shelf Life 1 Year
Storage Store at -20°C
Exact Mass 707.508
Hygroscopic No
Light Sensitive No
Percent Composition C 66.16%; H 9.82%; N 5.94%; O 18.08%
References 1. Haberkant P, Holthuis JC. Fat & fabulous: bifunctional lipids in the spotlight. Biochim Biophys Acta. 2014 Aug;1841(8):1022-30. doi: 10.1016/j.bbalip.2014.01.003. Epub 2014 Jan 15. PMID: 24440797. PubMed ID: 24440797.
2. Haberkant P, Raijmakers R, Wildwater M, Sachsenheimer T, Brügger B, Maeda K, Houweling M, Gavin AC, Schultz C, van Meer G, Heck AJ, Holthuis JC. In vivo profiling and visualization of cellular protein-lipid interactions using bifunctional fatty acids. Angew Chem Int Ed Engl. 2013 Apr 2;52(14):4033-8. doi: 10.1002/anie.201210178. Epub 2013 Feb 28. PMID: 23450850. PubMed ID: 23450850.

Reviews

If you have any suggestions or comments about mPEG-Br, please submit a review immediately.

submit

Related Link

Why BOC Sciences?

  • Large Stock

    More than 2000+ products in inventory

  • Global Delivery

    Warehouses in multiple cities to ensure fast delivery

  • mg to kg

    Multi specification for academic research and industrial production

  • 24/7 Technical Support

    Strict process parameter control to ensure product quality

Products

Resources

Our Feature

BOC Sciences supplies a unique variety of PEG derivatives and functional PEG polymers. Our products offer the most diverse collection of reactivity, ready-to-use functionality, and molecular weight options that you will not find anywhere else.

  • Our Feature icon1
  • Our Feature icon2
  • Our Feature icon3
  • Our Feature icon4
PEGylation of Peptides and Proteins

PEGylation of Peptides
and Proteins

Reduce the Immunogenicity of Peptide/Protein Drugs

Learn More

APPLICATIONS

APPLICATIONS

PEG linkers For Drug

Improved Circulation Half-Life

Learn More

Have Customer Reviewed On Us?

logo

Chat With Us

Online Inquiry

Verification code

Copyright © 2024 BOC Sciences. All rights reserved.